Publisher
Springer Science and Business Media LLC
Subject
Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology
Reference18 articles.
1. Li JQ, Welchowski T, Schmid M et al (2020) Prevalence and incidence of age-related macular degeneration in Europe: a systematic review and meta-analysis. Br J Ophthalmol 104(8):1077–1084
2. Tan CS, Ngo WK, Chay IW et al (2022) Neovascular age-related macular degeneration (nAMD): a review of emerging treatment options. Clin Ophthalmol 16:917–933
3. Swiss Agency for Therapeutic Products (2022) Vabysmo Public Summary SwissPAR. https://www.swissmedic.ch/swissmedic/en/home/about-us/publications/public-summary-swiss-par/public-summary-swiss-par-vabysmo.html. Accessed 10 Aug 2023
4. Heier JS, Khanani AM, Quezada Ruiz C et al (2022) Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE): two randomised, double-masked, phase 3, non-inferiority trials. Lancet Lond Engl 399(10326):729–740
5. Khanani AM, Aziz AA, Khan H et al (2023) The real-world efficacy and safety of faricimab in neovascular age-related macular degeneration: the TRUCKEE study–6 month results. Eye 37(17):3574–3581
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献